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Human umbilical cord blood, which in the past was discarded with the placental tissue,
provides a convenient source of fetal hemopoietic cells for scientific analysis and clinical use.
Cord blood cells are immature compared to analogous populations in adult peripheral
blood. Cord blood B lymphocytes display unique phenotypic and functional characteristics.
The antigens CDIC, CD38, CD5, and CD23, although normally expressed on only a small
percentage of circulating B cells in adults, are highly expressed on cord blood B cells. Recent
studies have demonstrated that whereas cord blood B cells are functionally naive, their
potential is similar to that of adult B cells if optimal T-cell help is available. Thus, the failure
of B-cell responses in cord blood is due to the T cells. The functional abnormalities of T cells
from newborns can be summarized as a dominance of the effects of TH0 cells. Thus, the
cytokines produced are immunosuppressive rather than mediating helper activity for B cells.
NK activity in cord blood is also depressed compared to that in adults. Cord blood is a very
rich source of hemopoietic progenitor cells. The spectrum of progenitors shows a predom-
inance of early progenitor cells when compared with bone marrow. These cells provide an
alternative source to adult bone marrow for stem cells to use for hemopoietic reconstitution
and as targets in the treatment of hereditary deficiencies by gene therapy. These features
make cord blood a unique research tool to investigate hemopoietic ontogeny and a unique
clinical tool for transplantation.
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INTRODUCTION
In early human development, as in that of other
mammals, it is believed that hemopoiesis begins in
the yolk sac. Primitive progenitors are thought to
migrate to fetal liver and finally to the bone marrow,
which remains the primary source of hemopoietic
cells throughout adult life. In keeping with this
model, erythropoietic activity is present in the liver
of the 6-week-old embryo with granulopoiesis oc-
curring a 7 weeks (Bloom and Bartelmez, 1940). The
fetal liver is the primary source of red cells from the
9th to the 24th week of gestation, whereas eythro-
poiesis and granulopoiesisis are first evident in the
bone marrow of the 10- to l 1-week-old embryo
(Bloom and Bartelmez, 1940). Hemopoietic activity
increases rapidly in the ensuing weeks with the
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marrow becoming the major site of hemopoiesis
after the 24th week of gestation. Although lym-
phopoiesis has not been observed in the yolk sac, it
is present in the lymphoid plexuses at 9 weeks and
in the lymph glands by 11 weeks of gestation
(Gupta et al., 1976).
Although transfer of hemopoietic activity from
the liver to the bone marrow is virtually complete
at the time of birth, it has been shown that human
umbilical cord blood (HUCB) is rich in hemopoietic
progenitor cells (Broxmeyer et al., 1989). Human
umbilical cord blood, which in the past was dis-
carded with the placental tissue, provides a conve-
nient source of fetal hemopoietic cells for scientific
analysis and clinical use. In this review, we will
examine the properties of lymphohemopoietic cells
in HUCB and outline the differences between
these cells and those found in adult peripheral
blood (Table 1). We will consider the hemopoietic
progenitor cells, B, T lymphocytes, and NK cells in
detail.2 F.M. CICUTTINI and A.W. BOYD
TABLE
A Comparison of Cell Populations in Cord Blood versus Adult Blood
Cord blood Adult blood References
Haemopoietic progenitor cells
% of total mononuclear <0.1
cells expressing CD34
B cells
Pre-B cells 0.7 0.2
(% of total lymphocytes)
B cells 11.4 5.4
(% of total lymphocytes)
% B cells expressing:
CDlc 90 15-20
CD23 70 10
CD38 90 15-20
T cells
% CD4+ T cells coexpressing:
CD29 <10 50
CD38 >90 10-20
CD45RA. >90 40-50
NK cells
% expressing:
CD16 80-90 80-90
CD57 <1 50-60
Cicuttini et al., 1992
Okino, 1987
Okino, 1987
Small et al., 1989
Small et al., 1989
Small et al., 1989
Clement et al., 1990
Clement et al., 1990
Clements t al., 1990
Tarakkanan and Saksela, 1982
Abo et al., 1982
Human Umbilical Cord Blood as a Source of
Hemopoietic Progenitor Cells
Circulating blood cells are derived and replaced by
the hemopoietic stem and progenitor cell pools
(Williams et al., 1987). Hemopoietic progenitor cells
are present in human adult bone marrow but also in
adult peripheral blood and umbilical cord blood
(Caracciola et al., 1989). All human hemopoietic
progenitor cells as well as bone marrow reconstitut-
ing (stem) cells express CD34-antigens (Civin et al.,
1987; Berensson et al.; 1988a, 1988b).
As the primary site of production of stem/
progenitor cells in human adults is the bone mar-
row (Allen and Dexter, 1984), autologous or major
histocompatibility complex-matched bone marrow
transplantation has become the standard means of
clinical hemopoietic reconstitution. However,
HUCB has been used to effect hematological re-
constitution, with sufficient stem cells available in
the cord blood obtainable from a single placenta to
reconstitute adult (Broxmeyer et al., 1989). In this
study, three unseparated cord blood samples were
shown to contain 1.9 _+ 1.5 x 106 granulocyte-
macrophage colony-forming cells (CFU-GM),
which compares favorably with the minimum
CFU-GM associated with successful engraftment in
adults receiving marrow autografts (mean [range]
1.3 [0.3-6.3] x 106) Douay et al., 1986) and
allografts (2.6 [0.5-5.5] x 106) (Ma et al., 1987).
Although normal adult blood has had some use as
an alternative source (To and Juttner, 1987), in
practice, the content of stem/progenitor cells is so
low that multiple leukophoreses are necessary (To
and Juttner, 1987). This is also a limitation in using
this source for in vitro studies, although the num-
ber of progenitor cells has been reported to in-
crease transiently in patients undergoing intense
chemotherapy or following G-CSF infusion (Juttner
et al., 1990).
In general, numbers of hemopoietic progenitor
cells are monitored by clonogenic assays. These
allow for the growth and differentiation of progen-
itor cells, resulting in hemopoietic colonies after
various periods of culture (Lajtha, 1979). In vitro
culture of HUCB has demonstrated multipotential
(CFU-GEMM), erythroid (BFU-E), and granulocyte-
macrophage (CFU-GM) progenitor cells (Leary et al.,
1984). A proportion of colonies also contains pro-
genitors that form secondary colonies when replated
in a secondary agar culture. This property suggests
that the colony arises from a single cell with limited
self-renewal properties. The frequency of cord blood
progenitors (number of colonies formed/number of
cells plated) equals or exceeds that of marrow and
greatly surpasses that of adult blood. Progenitor
cells from HUCB can be maintained for several
weeks in long-term liquid culture systems, suggest-
ing their production from more primitive cells
(Salahuddin et al., 1981; Smith and Broxmeyer,
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We recently described the purification of highly
purified CD34+ progenitor cells from HUCB by
immunodepletion followed by positive FACS sort-
ing (Cicuttini et al., 1992a). This resulted in > 100-
fold enrichment of colony-forming cells (CFC). Cord
blood progenitor cells were shown to be skewed to
very early cells in that cord blood CD34+ cells
grown in the presence of stem-cell factor (SCF), and
optimum growth factors resulted in a very high
proportion (50-80%) of mixed colonies (CFU-
GEMM). This was in agreement with another study
examining progenitors from cord blood (Broxmeyer
et al., 1991). However, significantly fewer CFU-
GEMM were observed when bone marrow was
cultured under similar conditions (Anderson et al.,
1990; Nocka et al., 1990; McNeice et al., 1991).
These findings suggest that the stem/progenitor cell
pool in cord blood is weighted toward very early
progenitor cells.
In our studies, we also examined the ability of
CFU-GEMM colonies to reclone. That is, the ability
of cells harvested from the CFU-GEMM colonies, on
reculturing in the presence of the same hemopoietic
growth factors, to form daughter colonies. This
would indicate that they contain more immature
CFC than have been described for CFU-GEMM
colonies derived from bone marrow or peripheral
blood, which have a very low recloning frequency.
We showed that CFU-GEMM colonies from HUCB
grown in the presence .of SCF did not contain
significant numbers of cells that could reclone. In
contrast, however, Carrow et al. (1991) demon-
strated a higher recloning frequency when the
primary colonies were derived from cultures stimu-
lated with erythropoietin and rMuSCF.
There are a number of explanations for the dif-
ferences between our results and those in this study.
The culture conditions we used differed in that
G-CSF and GM-CSF were included in our experi-
ments, together with erythropoietin and SCF. It is
possible that the balance between self-renewal and
terminal differentiation was different under our
conditions and led to rapid depletion of CFC. In our
experiments, CFU-GEMM colonies grown in the
presence of SCF contained 100-fold more cells than
those grown in the absence of SCF (Cicuttini et al.,
1992a). It may be that these large CFU-GEMM
colonies were due to limited self-renewal during the
early phase of colony formation. The progeny CFC
of these early divisions may have been recruited
into the formation of a large "aggregate" colony.
This possibility would be compatible with the ob-
servations of Carrow et al., (1991) and supports the
notion that the CFU-GEMM have a higher prolifer-
ative potential than the majority of BM CFU-
GEMM.
In Vitro Stem-Cell Assays
Secondary CFU (delta) assay for early hemopoi-
etic cells The secondary CFU assay involves the
short-term (7-day) suspension culture of bone mar-
row depleted of committed progenitors and en-
riched for early stem cells in the presence of various
cytokine combinations. The ability of these cytok-
ines to promote survival, recruitment, differentia-
tion, and expansion of stem cells and progenitor
cells is measured in a secondary clonogenic assay.
This secondary recloning assay has been used in a
number of experimental settings to determine
whether it can provide better information on the
quality of cells in a transplant or chemotherapy
regeneration situation (Juttner et al., 1985). We have
used this assay to examine subpopulations of he-
mopoietic cells from HUCB.
Rhodamine-123 (Rh-123) is a supra-vital fluoro-
chrome dye that is a useful tool for the hierarchical
ordering of transplantable hematopoietic stem-cell,
populations (Fauser and Messner, 1979). Recent
studies have demonstrated that the most primitive
cells in murine bone marrow have a low uptake of
Rh-123, that is, Rh-123
lw (Bertoncello et al., 1985;
Ploemacher and Brons, 1989). The potential of
Rh-123 to distinguish between functionally distinct
but closely related populations of primitive human
hematopoietic cells has recently been examined.
Double staining of human bone marrow with Rh-
123 and phycoerythrin-labeled anti-CD34 Ab has
demonstrated that the most primitive human he-
matopoietic cells are CD34+ Rh-123lw (Udomsakdi
et al., 1991).
We subdivided the CD34 HUCB cells on the basis
of Rh-123 staining and examined single cytokines
and cytokine combinations to investigate whether
they could maintain survival, differentiation, and
expansion of progenitor cells in the secondary CFC
assay (Cicuttini, unpublished observation). Al-
though an expansion of clonogenic cells was ob-
served in.cultures of the CD34+ Rh-123high and the
total CD34+ ceils, the CD34+ Rh-123w cells were
found o produce the largest expansion of clonogenic
cells, with Epo and SCF resulting in the most
marked amplification. Following 7-day culture with
combination of IL-3, IL-6, and SCF, the CD34+4 F.M. CICUTTINI and A.W. BOYD
Rh-123lw cells resulted in a 50-fold expansion of
CFC compared to an 0.8- and 0.9-fold expansion for
the CD34+ Rh-123high and the total CD34+ cells.
This is a larger expansion than was recently de-
scribed for adult peripheral blood CD34+ cells
cultured in a 6-factor combination for 7 days, where
a 39-fold expansion was measured (Haylock et al.,
1992). These results show that the CD34+ Rh-
123lw population contains the more immature pro-
genitor cells with a large capacity for maintenance
and expansion of clonogenic cells. These data also
support the notion that fetal (cord blood) progenitor
cells have a greater potential for expansion than
adult progenitor cells.
Long-term culture-initiating cells In vitro he-
mopoiesis for weeks or months can be achieved in
culture systems in which primitive hemopoietic
stem cells are maintained in intimate relationship
with a layer of marrow-derived stromal cells. These
long-term bone marrow cultures (LTBMC) were first
developed to support murine stem cells (CFU-S)
replication (Dexter et al., 1977) and were subse-
quently adapted to sustain long-term hemopoiesis
with marrow derived from other species including
humans (Moore and Sheridan, 1971; Moore et al.,
1979). Long-term culture is a more reliable measure
of primitive progenitor cells than CFU-GM assay
(Sutherland et al., 1989). Unlike normal bone mar-
row cells, cord blood cannot be established in
primary long-term culture because it does not con-
tain sufficient stromal precursor cells to provide the
microenvironment necessary for self-renewal and
differentiation of hemopoietic cells (Hows et al.,
1992). However, when preformed marrow stroma
was provided, CD34+ cells from HUCB could pro-
duce CFC for many weeks in culture (Cicuttini et al.,
1992b). Indeed, the amplitude and length of pro-
genitor cell production from cord blood in culture
were shown to be superior to those of normal bone
marrow, suggesting that the proportion of marrow
"stem" cells is greater (Hows et al., 1992).
Long-term culture-initiating cells (LTC-IC) are
defined, and can be assayed, by their ability to
sustain prolonged (weeks) hemopoiesis and progen-
itor cell generation when inoculated onto preformed
irradiated marrow stroma. In recent studies, the
combination of negative selection by depletion of
lineage positive cells, foll’owed by positive selection
for CD34+ cells exhibiting low right angle and low
forward light-scatter properties, has permitted the
enrichment of a population of cells possessing long-
term culture-initiating properties (Andrews et al.,
1989, 1990; Brandt et al., 1990; Verfaillie et al.,
1990). We examined the various CD34+ subpopu-
lations in human cord blood for the presence of
LTC-IC by using stromal-cell lines (SCL) in which
the rate of proliferation could be controlled by
altering the zinc concentration (Cicuttini et al.,
1992b). As we have reported (Cicuttini et al.,
1992b), suppression of SCL proliferation by removal
of zinc (Zn) made it possible to use these lines in
co-culture with purified CD34+ subpopulations of
cells. The line used, SCL 11, has been shown to
produce GM-CSF, G-CSF, IL-6, and SCF/KL, but
no IL-3 (Cicuttini et al., 1992b). CFC could be
measured for over 2 months in co-cultures of SCL11
and CD34+ Rh-123w cells compared to only 40
days in cultures of CD34+ Rh-123high. Significantly
more total CFC were generated in co-cultures of the
CD34+ Rh-123lw cells. As was previously ob-
served for human bone marrow (Udomsakdi et al.,
1991) and adult peripheral blood (Udomsakdi et al.,
1992), these results confirm that LTCIC are present
within the CD34+ Rh-123
lw population from cord
blood.
B Lymphocytes
Human umbilical cord blood has been shown to be
enriched for pre-B and B cells compared to adult
peripheral blood. The mean frequency of pre-B cells
has been shown to be 0.7% of total lymphocytes in
cord blood compared to 0.2% in adult blood (Okino,
1987). The mean relative frequency of B lympho-
cytes in cord blood is also higher, being 11.4% of
total lymphocytes compared to 5.4% in adult blood
(Okino, 1987). In terms of absolute numbers of
pre-B cells, cord blood contains ten times the num-
ber in adult blood.
The system of humoral immunity (B cells) devel-
ops early in gestation (Pabst and Kreth, 1980), but is
not fully developed until after birth. Cord blood B
lymphocytes display unique phenotypic and func-
tional characteristics. The antigens CDIC, CD38,
CD5, and CD23 are highly expressed on cord blood
B cells but are expressed on only a small percentage
of circulating B cells in normal adults (Small et al.,
1989). Approximately half of the surface Ig B
lymphocytes express the CD5 Ag (Antin et al., 1986;
Bofil et al., 1985; Durandy et al., 1990). The signif-
icance of the presence of CD5 on newborn B
lymphocytes remains unclear. CD5+ B lympho-
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(Antin et al., 1986) and cord blood (Bofil et al.,
1985), are not found at such high levels in adult-
hood. However, CD5 + cells are increased in patho-
logical conditions such as autoimmune disease or
lymphoproliferative diseases (Boumsell et al., 1980;
Plater-Zyberg et al., 1985; Hardy and Hayakawa,
1986; Sthoeger et al., 1989).
In addition to CD5 expression, a significant pro-
portion of both CD5+ and CD5- newborn B cells
express activation antigens (Durandy et al., 1990).
Half of the slg+ lymphocytes express the transferrin
receptor and 10% the antigen defined by the Bac-1
mAb, both being early activation markers; (Larrick
and Cresswell, 1980; Haynes et al., 1981). CD23,
which has been shown to be a low-affinity Fc
receptor of IgE (Bonnefoy et al., 1987), is also found
on a significant number of B cells (Durandy et al.,
1990). The detection of CD23 on normal resting
cord blood B cells may not always reflect B-cell
activation (Small et al., 1989). In this respect, it
resembles the discontinuous expression of CD38
during normal B-cell ontogeny. CD38 is not only
seen on resting and circulating cord blood B cells,
but also on terminally differentiated plasma cells,
with minimal expression on resting, circulating adult
B cells (van Camp et al., 1982; Tedder et al., 1984;
Small et al., 1989).
Despite the increased numbers of B cells in cord
blood, Ig secretion is generally lower than in the
adult. Cord blood B cells proliferate normally to
Staphylococcus aureus Cowan strain 1 (SAC) and
secrete IgM in response to a variety of polyclonal
B-cell activators. However, very low immunoglobu-
lin secretion is seen is pokeweed-mitogen- (PWM)
stimulated cord blood mononuclear cells (Wu et al.,
1976; Hayward and Lawton, 1977). Minimal or no
IgG or IgA is produced following stimulation with
pokeweed mitogen (Small et al., 1990) and SAC,
and normal adult B cells, in response to these
mitogens, produce both isotypes. Low immunoglo-
bulin secretion (IgM with few IgG and almost no
IgA) is found in B-cell assays that, unlike the PWM
system, do not depend on a cell contact-mediated
helper T-cell activity. These studies describe activa-
tion of isolated B cells with SAC or anti-t antibodies
plus various cytokines (Durandy et al., 1990). In
contrast to the low levels of IgA and IgG secretion,
cord blood B cells do switch to IgE-producing cells in
response to interleukin-4 (IL-4) in vitro (Pastorelli et
al., 1990). The minimal levels of IgE production
measured in cord blood (less than 1 U/ml) are not
due to a switching defect in cord blood B cells, but
may be associated with the failure of cord blood T
cells to produce detectable levels of IL-4.
Until recently, no in vitro B cell system was able to
produce adult levels of IgG and IgA responses in
newborn B cells. Recent studies suggest that
whereas cord blood B cells are probably functionally
naive, their inherent potential to switch to down-
stream isotypes approaches that of adult B cells.
Tucci et al. (1991) examined isotype secretion in a
culture system in which a direct cell contact with
mutant EL4 thymoma cells, in conjunction with
human T-cell supernatants, could lead to B-cell
activation. It was shown that cord B cells, if pro-
vided with the extremely potent signals supplied by
the mutant EL4 thymoma and T-cell supernatants,
did reveal a potential for differentiation that was
both qualitative and quantitatively indistinguishable
from adult B cells. Hirohata et al. (1988) described a
method for generating high-rate immunoglobin pro-
duction from human B cells by co-culturing them
with T cells that were stimulated with immobilized
antibody to CD3. The production of both IgG and
IgA, in addition to IgM, was observed, although the
amounts of the switched isotypes produced were
small by comparison to adult B cells. More recently,
the frequency of B cells responding in this system
was estimated and the factors modifying the re-
sponse determined (Amoroso and Lipsky, 1990).
The optimal response was observed with the addi-
tion of IL-2 and accessory cells when B-cell re-
sponses to anti-CD3-activated normal T cells
reached a precursor frequency of 60-80%. Immu-
noglobin secretion of multiple isotypes was ob-
served in wells where single B cells were seeded,
indicating that class switching was occurring in
these cultures. This contact-dependent activity ex-
pressed by activated TH cells has been shown to be
due to triggering of the CD40 molecule via its
ligand, CD40L, a 33-kD membrane protein (Brian,
1988; Armitage et al., 1992).
In summary, cord blood is enriched for pre-B and
B lymphocytes compared to adult peripheral blood.
Neonatal B lymphocytes display unique phenotypic
and functional characteristics. The antigens CDIC,
CD38, CD5, and CD23 are highly expressed on cord
blood B cells but are normally expressed on only a
small percentage of circulating B cells in normal
adults. Recent studies suggest that whereas neonatal
B cells are probably functionally naive, their inher-
ent potential for stimulation approaches that of
adult B cells. This can be realized as long as
sufficiently strong T-cell help is available.6 F.M. CICUTTINI and A.W. BOYD
T cells
Phenotypic markers of differentiation The per-
centage of lymphocytes expressing the CD2, CD3,
and CD8 markers are lower in cord blood than adult
blood. However, due to the increased white cell
count in cord blood, the absolute numbers of CD2 +
and CD8+ cells are comparable (Gerli et al., 1989).
In contrast, the percentages of CD4+ cells (helper/
inducer T cells) in cord blood and adult peripheral
blood are similar, although the absolute numbers of
CD4+ cells are higher in cord blood. Nevertheless,
cord blood CD4 + cells are deficient in their ability to
provide help for antibody production. The func-
tional abnormalities of cord blood T cells can be
summarized as a relative absence of helper activity
(Anderson et al., 1983). The cellular basis for this
functional deficit has been examined by analyzing
the phenotypic properties and immunoregulatory
functions of subsets of cord blood CD4 + cells.
Recently, surface markers have been identified
that seem to distinguish between "naive" versus
"memory" T cells (Kingsley et al., 1988; Notaran-
gelo et al., 1988; Landesberg et al., 1988; Sanders et
al., 1988; Bradley et al., 1989; Clement et al., 1990).
In contrast to CD4+ cells from adults, greater than
90% of cord blood CD4 + cells express high levels
of CD45RA and L-selectin (Leu-8) (Clement et al.,
1990) and have low levels of CD45RO (Sanders et
al., 1988). The CD45RA antigen is first expressed by
T-lineage cells relatively late during their intrathy-
mic maturation and continues to be expressed by
most T cells in the immunologically naive neonate
(Clement, 1992). However, with increasing age and
antigenic exposure CD45RA-/RO+ cells become
more prevalent in the circulation and comprise the
majority of cells in tissues. Analysis of the functional
capabilities of CD4+CD45RA+ and CD4CD45RO+
cells has shown that proliferative responses to
"memory" recall antigens, or the ability to provide
help for antibody production, correlate with
CD4+CD45RA-/RO+ cells (Clement et al., 1990).
The major immunoregulatory functions described
for CD4+CD45RA+ cells involve inhibition of im-
mune responses, either directly or via the induction
of suppressive activity by CD8+ cells.
Although cord blood CD4+CD45RA+ and
CD4+CD45Ra- cells share certain properties with
the analogous subsets in adults, the dominant im-
munoregulatory phenotype of cord blood CD4+
cells has been shown to be largely immunosuppres-
sire, this phenotype being essentially consistent
with the preponderance of CD4+CD45RA+ (and
CD38+) cells (Tosato et al., 1980; Jacoby and Old-
stone, 1983; Clement et al., 1990). Cord blood
CD4 + cells cultured with adult B cells and PWM, or
anti-CD4 + mAb, demonstrated no helper function
(Clement et al., 1990). However, after activation
with PHA and culture in IL-2, cord blood
CD4+ + CD45RA+ cells acquired the ability to pro-
vide help for B-cell differentiation. This functional
maturation was accompanied by conversion to the
CD4+CD45RA-CD45RO+ phenotype.
However, when the small number of
CD4+CD45RA-CD45RO+ cells in cord blood were
purified and similarly analyzed, helper activity com-
parable to that of adult CD4+CD45RA- cells was
found (Clement et al., 1990). This helper function
was blocked by the presence of even small numbers
of cord blood (but not adult) CD4+CD45RA+ cells.
Irradiation or mitomycin C treatment of cord blood
CD4+CD45RA+ cells abrogated their suppressive
activity, but did not induce helper capability. In
view of these phenotypic and functional differences
between cord blood and adult CD4+CD45RA+
cells, it has been proposed that "naive"
CD4+CD45RA+ cells undergo age-related matura-
tional changes that are unrelated to their postulated
activation-dependent post-thymic differentiation
into CD4+CD45RA- "memory" cells capable of
helper functions (Clement et al., 1990).
Cytokine production CD4 + T lymphocytes in
the mouse were originally divided into at least two
functionally distinct subsets base upon the pattern
of lymphokines secreted (Mosmann and Coffman,
1989; Street and Mosmann et al., 1991). One subset
referred to as TH1 cells produce IL-2, IFN-gamma
and lymphotoxin upon activation. A second subset,
type 2 helper T (TH2) cells, secrete IL-4, IL-5, IL-6,
and IL-10. Both TH types express IL-3, GM-CSF,
and TNF. The action of murine TH1 and TH2 T-cell
subsets appeared to be mutually antagonistic. The
TH1 and TH2 phenotypes were originally defined
as very distinct cytokine secretion patterns ex-
pressed by large numbers of independently derived
T-cell clones in a mutually exclusive fashion. Since
that original definition, it has become clear that a
number of other cytokine-secretion phenotypes are
displayed by T-cell clones in tissue culture, and
some of these phenotypes are stable and have been
obtained in independent experiments (Kelso et al.,
1991). A phenotype known as TH0 is characterized
by the simultaneous secretion of IL-2, IL-4, IL-5,CORD BLOOD PROGENITOR CELLS 7
IL-10, and IFN-gamma. It is thought that the TH0
phenotype represents a transient multipotential
stage of CD4+ T cells that may differentiate further
to the more restricted TH1 or TH2 phenotype. The
THp precursor cell secretes only IL-2 on first contact
with antigen. It is thought that the other pheno-
types are derived either from this cell via a single
step or, alternatively, that the exteme phenotypes,
TH1 and TH2, are derived from intermediate phe-
notypes (Mosmann et al., 1991). Initially, it did not
appear that human CD4+ cells could be separated
into TH1 and TH2 cell types. However, there is now
clear evidence for the differential production of
lymphokines by human CD4+ T cells (Yessel et al.,
1990).
The naive T lymphocytes found in cord blood
produce a pattern of lymphokine production resem-
bling that of THp cells upon restimulation, as, for
example, by anti-CD3 antibodies in vitro (Ehlers and
Smith, 1991). They respond to activation by prolif-
eration, yet cannot secrete effector lymphokines
other than IL-2. Cord blood T cells have a signifi-
cantly enhanced proliferative responsiveness to IL-2
and an enhanced production of IL-2 compared to
adult T cells (Rizzo et al., 1987; Fairfax and Borzy,
1988). In contrast, production of IL-4 by cord blood
CD4 T cells, and IFN-gamma by cord blood
CD4 + and CD8 + T cells, is less compared with
analogous adult cell populations (Pastorelli et al.,
1990; Lewis et al., 1991). Transcription of IL-4 is
undetectable in cord blood T cells (TH2), and IFN-
gamma transcription and IFN-gamma mRNA-
containing cells (TH1) are reduced in cord blood T
cells compared with adult T cells. Reduced lym-
phokine production by cord blood T cells correlates
with their lack of a CD45RO (putative memory
T-cell) population. Levels of IFN-gamma signifi-
cantly higher than those produced by adult T cells,
however, are synthesized in response to combina-
tions of PHA and TPA, indicating that IFN-gamma
production by cord blood T cells is not intrinsically
defective. It might be speculated that the lack of
B-cell help in cord blood T cells is a function of a
more THp-like pattern of cytokine secretion.
In summary, the functional abnormalities of cord
blood T cells can be summarized as dominance of
suppression over helper activity with more than
90% of CD4 + T cells in cord blood expressing a
naive phenotype, which may explain their helper
activity. Their cytokine profiles suggest that they are
THp cells.
Natural Killer (NK) Cells
Human NK cell activity develops gradually during
intrauterine life (Uksika et al., 1983). Although cells
bearing the NK marker CD57 + are negligible in
cord blood (Abo et al., 1982), the proportions of
CD16 + lymphocytes are equal to those of adult
peripheral blood (Tarakkanan and Saksela, 1982;
Perussia et al., 1983). The NK activity, of newborn
peripheral blood is lower than that of adult blood
(Uksila et al., 1982; Uksila et al., 1983) but can be
enhanced by IL-2 (Ueno et al., 1985) and interferon
(IFN) (Herberman and Ortaldo, 1981; Trinchieri and
Perussia, 1984; Hercend and Schmidt, 1988). Al-
though spontaneous NK activity of cord blood cells
is profoundly reduced compared to the adult,
antibody-dependent cellular cytotoxiciy and NK-
like activity generated in mixed lymphocyte cultures
are similar in the two groups, with lymphokine-
activated killer-cell (LAK) activity being higher in
the neonate.
rHuIL-2 potentiates the cytotoxicity of cord blood
CD16+ cell to approximately adult levels (Ueno et
al., 1985) and significantly potentiates cytotoxic
activity of both CD16- cells.from cord blood and
adult blood that have no basal NK activity. IL-2 can
also enhance depressed NK activity even at an early
stage of human development, whereas NK boosting
by IFN-gamma occurs effectively only during the
latter half of gestation (Perussia et al., 1983). These
results suggest that cord blood NK cells are hetero-
geneous and rIL-2 and gamma-IFN might potentiate
the cytotoxicity of functionally immature NK cells or
NK precursor cells. The existence of IL-2-sensitive
NK precursors or functionally immature NK cel.ls
has been postulated, but the nature of these cells
has not been determined (Uksila et al., 1982)
We have described the isolation of a unique
subpopulation of CD7+ cells from human umbilical
cord blood that in part corroborates and extends
these earlier observations (Cicuttini et al., 1993). By
immunorosette depleting .of umbilical cord blood
using T-cell, B-cell, granulocyte, macrophage, and
hemopoietic progenitor cell (CD34) markers to iso-
late a lineage marker negative (Lin-) population, a
relatively homogeneous population was isolated
with over 90% of cells expressing CD7. This
Lin- CD7+ population was shown to be negative
for all other T-cell markers tested (i.e.,
CD7 + 1 2 3 4 8 ). However, approximately
30% of these cells were positive for the natural-
killer (NK) cell-surface markers CD16 and CD568 F.M. CICUTTINI and A.W. BOYD
(CD7 + NK + ). Both CD7 + NK + and CD7 + NK-
populations proliferated in response to stimulation
in vitro with IL-2/phytohemagglutinin (PHA)/
PHA-conditioned medium. After such treatment,
approximately 40% of the CD7+NK- acquired
CD16 and CD56, and about 20% of the CD7+NK+
population became CD2 +. The significance of the
60% of CD7+NK- cells that did not acquire other
markers remains to be determined. In addition,
although neither population was cytotoxic when
first isolated, both populations acquired the ability
to lyse the NK target cell line K562 when cultured
under these conditions.
These data suggest that these two populations
may represent a developmental sequence amongst
NK cell precursors in human umbilical cord blood.
We have clearly isolated precursor cells that ante-
cede the acquisition of cytotoxic function. In partic-
ular, the CD7+NK- cells may be good candidates
for the most immature NK precursor cells in cord
blood and may represent cells recently released from
bone marrow. Further analysis of such precursors
may be useful in understanding the ontogeny of NK
cells in vivo.
Clinical Uses for Cord Blood
Bone marrow transplantation is now recognized as
an effective form of treatment for an increasing
number of malignant and nonmalignant disorders.
Unfortunately, suitable marrow is frequently not
available, with either the patient’s own marrow
being contaminated with tumor cells or potential
allogenic marrow donors being unsuitable on the
basis of HLA disparity or prior alloimmunization.
Two-thirds of patients with leukemia and other
life-threatening bone marrow diseases lack HLA-
identical sibling marrow donors, and must rely on
finding histocompatible donors through volunteer’s
registries (Beatty et al., 1988). Thus, many patients
die or deteriorate before suitable transplant donors
can be found (Ruuta et al., 1990). In addition, the
risk of life-threatening acute graft-versus-host dis-
ease after unrelated marrow transplantation is high
compared with the risk of HLA-identical sibling
transplantation (Beatty et al., 1991).
HUCB may be one potential source of hemopoi-
etic stem cells. HUCB is rich in hemopoietic pro-
genitor cells, as measured in standard clonogenic
assays for burst-forming units and granulocyte-
macrophage colony-forming cells (Broxmeyer et al.,
1989). HUCB has resulted in successful engraftment
in a number of patients (Broxmeyer et al., 1991).
Cryopreserved HUCB may be an alternative to bone
marrow as a source of hemopoietic "stem" cells for
HLA-identical transplantation. It has been sug-
gested that a type cord blood bank would not only
supplement the pool of registered marrow donors,
especially in underrepresented ethnic and social
groups, but could also potentially shorten the time
between the initiation of an unrelated donor search
and time of transplantation (Hows et al., 1992).
Cord blood may be considered for treatment of
leukemia, lymphoma, marrow-failure syndrome,
and inborn errors of metabolism in patients who
might benefit from myeloablative therapy and the
infusion of normal hematopoietic stem cells.
A further use for HUCB is in g.ene therapy for
hereditary deficiencies. The correction of certain
human genetic defects might be possible by intro-
ducing functional genes into repopulating stem cells
(Karson et al., 1992). The hemopoietic system is a
primary target for attempting somatic gene therapy.
Several leading laboratories recently have been able
to demonstrate that bone marrow cells can be
successfully transduced with foreign genes, result-
ing in the functional expression of these genes in
culture. Retroviral vectors containing marker genes
and the sequence for human proteins have been
used to transduce cultured lymphocytes, which
have then been reinfused into patients. Circulating
hempoietic progenitor cells from human cord blood
obtained at the time of term and premature deliv-
eries as early as 19 weeks of gestation have been
shown to express such transduced genes in vitro.
Cord blood cells from fetal sheep sampled and
transduced in vitro and transfused back in utero
have been shown to express marker genes up to 2
years after birth. Although the efficiency of gene
transfer into cells and their long-term expression
need to be improved, the potential exists for treating
some genetic diseases after prenetal diagnosis either
in utero or shortly after birth (Karson et al., 1992)
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